Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts

Blood, Vol. 109, Issue 9, 4097-4104, May 1, 2007
This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

Selective targeting of the LIGHT-HVEM costimulatory system for the treatment of graft-versus-host disease
Blood Xu et al. 109: 4097

Supplemental materials for: Xu et al, Blood, Vol. 109, Issue 9, 4097-4104

Files in this Data Supplement:

  • Figure S1. Biological characteristics of LBH1 (JPG, 99.8 KB) -
    (A, top) 293T cells transfected with either full-length mouse HVEM (filled histogram) or control vector (open histogram) were stained with 1 µg LBH1 (right) or control hamster IgG (left), followed by PE-conjugated anti–hamster IgG Ab. Human 293T transfected with full-length mouse LIGHT (middle) or mouse BTLA (bottom) were stained with 2 µg mouse HVEM-mouse Ig fusion protein (filled histogram) or control mouse Ig protein (open histogram) in the presence of 10 µg/mL LBH1 (right) or control hamster IgG (left). Staining intensity of fusion protein was detected by FITC-conjugated anti–mouse Ig Ab. (B) Agonistic activity of LBH1 was examined in vitro by T cell costimulation assay. Tissue culture plate was coated with graded doses of anti–CD3 mAb (2.5-20 µg/mL) and further with 10 µg/mL LBH1 (black triangles) or control hamster IgG (white squares). Purified B6 T cells (1 × 106 cells/mL) were cultured in the wells for 3 days, and the proliferation activity during the last 15 hours was measured by 3H-thymidine incorporation assay. As positive control, 3 µg/mL anti–CD28 mAb was added in the wells at the beginning of T-cell culture (white circles).





  • Figure S2. Preferential reduction of LIGHT-KO donor T cells compared to WT donor T cells in the single BDF1 host (JPG, 62.9 KB) -
    Purified Thy 1.1 WT B6 T cells (7 × 106 cells) were mixed with Thy1.2 LIGHT-KO B6 T cells (7 × 106 cells) and transferred intravenously into BDF1 recipient mice. After 11 days, absolute number of donor T cells in the host spleen was assessed by FACS analysis calculating H-2Kd-negative, Thy1.2, or Thy1.1-positive donor T cells. As control, the mixture of same numbers of Thy1.1 WT B6 T cells and Thy1.2 WT B6 T cells were transferred intravenously into BDF1 mice, followed by analysis of cell number on day 11. Each dot represents the data of individual mouse. *P = .038.





  • Figure S3. Minor role of host-derived LIGHT in allo-CTL generation (JPG, 63.7 KB) -
    Either WT (black squares) or LIGHT-KO (white squares) B6 mice were exposed to sublethal irradiation (6 Gy), followed by an intravenous injection of 5 × 107 BALB/c spleen cells on day 0. On day 7, host spleen cells were harvested, and anti-allo CTL activity was assessed by 51Cr-release assay against EL4 (H-2b) and A20 (H-2d) tumors as target cells.





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020